Bariatric Times - Supplement A - Covidien - (Page 2)

CONTENTS LAPAROSCOPIC SLEEVE GASTRECTOMY: FROM MAGENSTRASSE AND MILL TO SLEEVE by Michael J. McMahon, ChM, PhD, MD (HON), FRCS PAGE 3 SLEEVE GASTRECTOMY PROVIDES RESOLUTION OF TYPE-2 DIABETES WITHOUT DUODENAL EXCLUSION by Michel Gagner, MD, FRCSC, FACS PAGE 5 THE RELATIONSHIP BETWEEN THE RESECTED REMNANT AND WEIGHT LOSS by Rudolf A. Weiner, MD, PhD PAGE 7 LAPAROSCOPIC SLEEVE GASTRECTOMY: RESULTS AFTER TWO AND FIVE YEARS by Jacques M. Himpens, MD PAGE 9 LAPAROSCOPIC SLEEVE GASTRECTOMY AS AN INITIAL WEIGHT LOSS PROCEDURE FOR HIGH-RISK PATIENTS WITH MORBID OBESITY by Samer G. Mattar, MD, FACS PAGE 11 THREE-YEAR RESULTS OF LAPAROSCOPIC SLEEVE GASTRECTOMY IN THE TREATMENT OF MORBID OBESITY IN KOREA by Wonwoo Kim, MD PAGE 13 LAPAROSCOPIC SLEEVE GASTRECTOMY: NUTRITIONAL CONCERNS AND POSTOPERATIVE DIETARY CARE by Greg Dakin, MD PAGE 15 LAPAROSCOPIC SLEEVE GASTRECTOMY: PREVENTION AND TREATMENT OF BLEEDING by Alfons Pomp, MD, FACS PAGE 17 PREVENTION AND TREATMENT OF GERD/HIATAL HERNIA AND STENOSIS ASSOCIATED WITH SLEEVE GASTRECTOMY by Gregg H. Jossart, MD; Paul T. Cirangle, MD PAGE 19 LAPAROSCOPIC REVISIONS OF SLEEVE GASTRECTOMY by Raul J. Rosenthal, MD, FACS PAGE 21 SURVEY RESULTS Page 23 2 LETTER The first International Consensus Summit on Sleeve Gastrectomy took place in New York City in October 2007, with nearly 350 faculty experts, registrants, and technical exhibitor attendees. Divided into three parts, the meeting’s first day was dedicated to live surgical procedures of various laparoscopic sleeve gastrectomies, performed by surgical teams that were lead by Alfons Pomp, MD, W.B. Inabnet, MD, Subhash Kini, MD, and George Ferzli, MD, and also included some pre-recorded, unedited videos of my own collection. The second day included oral presentations of laparoscopic sleeve gastrectomy’s efficacy, technical aspects, mid- and long-term results, complications, prevention, reoperations, revisions, and second stages. Half of the faculty and attendance was from overseas, especially from Europe and South America. Finally, the third day was special, and had an international consensus summit of experts who voted and debated on several important (sometimes controversial) questions regarding laparoscopic sleeve gastrectomy. Information from this summit can be found on Page 23 of this supplement. Some of the highlights of the meeting included presentations on the resolution of type-2 diabetes with the sleeve as a successful metabolic operation, and also for the first time, two-, three, and five-year results on the efficacy of weight loss and resolution of comorbidities from teams in the US, UK, Belgium, and Germany. New ways to perform the sleeve and avoid and treat complications (like endluminal stenting) were also presented. The mechanisms of sleeve gastrectomy seemed to move from the purely restrictive explanation to a hormonal hypothesis, also implying modified gastric emptying. The operation seems to have passed the experimental phase and is now clinically established—in more than 35 countries worldwide—with a broad range of indications, but more specifically in high-risk patients and the elderly, in special, difficult, clinical situations, and also as part of second-stage strategies. The meeting was extremely well received, as compiled from the satisfaction survey after the meeting. As a result of this meeting, several national healthcare organizations have embraced this new procedure. A second International Consensus Summit on Sleeve Gastrectomy will be held in Miami Beach, Florida, March 19–21, 2009, at the newly renovated famous Fontainebleau Hotel, with the same format. We expect more participation, with a first day of live surgery that will encompass new sleeve techniques, revisions, reoperations, and second stages; a second day with new updates on mechanisms, long-term results, and complications management; and a third day of panel discussions and voting on controversies and new statements. We hope you find the selections from the presentations that we’ve chosen for this supplement to be thought-provoking, informative, and practical for your surgical practice. Sincerely, Michel Gagner, MD, FRCSC, FACS

Table of Contents Feed for the Digital Edition of Bariatric Times - Supplement A - Covidien

Bariatric Times - Supplement A - Covidien Contents Laparoscopic Sleeve Gastrectomy: From Magenstrasse And Mill To Sleeve Sleeve Gastrectomy Provides Resoultion of Type-2 Diabetes Without Duodenal Exclusion The Relationship Bewtween The Resected Remnant And Weight Loss Laparoscopic Sleeve Gastrectomy: Results After Two And Five Years Laparoscopic Sleeve Gastrectomy As An Initial Weight Loss Procedure For High-Risk Patients With Morbid Obesity Three-Year Results Of Laparoscopic Sleeve Gastrectomy In The Treatment Of Morbid Obesity In Korea Laparoscopic Sleeve Gastrectomy: Nutritional Concerns And PostOperative Dietary Care Laparoscopic Sleeve Gastrectomy: Prevention And Treatment Of Bleeding Prevention And Treatment Of Gerd/Hiatal Hernia And Stenosis Associated With Sleeve Gastrectomy Laparoscopic Revisions Of Sleeve Gastrectomy Survey Results

Bariatric Times - Supplement A - Covidien

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.